Tatalaksana Penutupan Duktus Arteriosus Persisten Transkateter
DOI:
https://doi.org/10.55175/cdk.v48i6.80Keywords:
Duktus arteriosus persisten, penutupan cara transkateterAbstract
Penyakit jantung bawaan (PJB) merupakan salah satu kelainan bawaan terbanyak di dunia. Secara umum, kelainan ini dibagi menjadi tipe sianotik dan asianotik. Duktus arteriosus persisten (DAP) merupakan salah satu tipe PJB asianotik dan menduduki peringkat ke-3 dari seluruh kelainan jantung bawaan. Penutupan DAP secara transkateter saat ini menjadi pilihan utama jika gagal dengan obat-obatan dan ukuran defek memungkinkan. Pengamatan pasca-penutupan transkateter penting untuk menilai perubahan klinis dan kemungkinan komplikasi.
Congenital heart disease (CHD) is one of the most frequent congenital anomalies in the world. These anomalies are usually divided into cyanotic and acyanotic type. Patent ductus arteriosus (PDA) is acyanotic type of CHD and ranked 3rd of all CHD. Transcatheter PDA closure now becomes first choice if drug treatment fails and the size of the defect is qualified for nonsurgery closure. Post-closure observation is important to assess clinical changes and possible complications.
Downloads
References
Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of congenital heart disease: The glass half empty. Circ Res. 2013;112(4):707-20.
Van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241-7.
Hariyanto D. Profil penyakit jantung bawaan di instalasi rawat inap anak RSUP Dr. M. Djamil Padang Januari 2008 – Februari 2011. Sari Pediatri. 2012;14(3):6.
Maramis PP, Kaunang ED, Rompis J. Hubungan penyakit jantung bawaan dengan status gizi pada anak di rsup Prof. Dr. R. D. Kandou Manado tahun 2009-2013. e-CliniC. 2014 (Vol 2, No 2 (2014): Jurnal e-CliniC (eCl)).
Johnson W, Moller J. Classification and physiology of congenital heart disease in children. In: Johnson W, Moller J, editors. Pediatric cardiology: The essential pocket guide. 3rd Ed. Chennai: John Wiley & Sons; 2014. p. 87.
Perloff J, Marelli A. Patent ductus arteriosus. In: Perloff J, Marelli A, editors. Perloff's clinical recognition of congenital heart disease. 6th Ed. Philadelphia: Elsevier; 2012. p. 368-93.
Pourarian S, Farahbakhsh N, Sharma D, Cheriki S, Bijanzadeh F. Prevalence and risk factors associated with the patency of ductus arteriosus in premature neonates: A prospective observational study from Iran. J Matern Fetal Neonatal Med. 2017;30(12):1460-4.
Djer MM, Saputro DD, Putra ST, Idris NS. Transcatheter closure of patent ductus arteriosus: 11 years of clinical experience in Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Pediatr Cardiol. 2015;36(5):1070-4.
Djer MM, Salamia Idris N, Angelina A. Transcatheter closure of tubular type patent ductus arteriosus using Amplatzer ductal occluder II: A case report. Paediatr Indones. 2013;53(5):291-4.
Backes CH, Rivera BK, Bridge JA, Armstrong AK, Boe BA, Berman DP, et al. Percutaneous patent ductus arteriosus (PDA) closure during infancy: A meta-analysis. Pediatrics. 2017;139(2):e20162927.
Gournay V. The ductus arteriosus: Physiology, regulation, and functional and congenital anomalies. Arch Cardiovasc Dis. 2011;104(11):578-85.
Bökenkamp R. Developmental anatomy of the ductus arteriosus. In: Obladen M, Koehne P, editors. Interventions for persisting ductus arteriosus in the preterm infant. 1st Ed. Berlin: Springer; 2005. p. 2-5.
Jakanani GC, Adair W. Frequency of variations in aortic arch anatomy depicted on multidetector CT. Clin Radiol. 2010;65(6):481-7.
Schrör K. Prostaglandin metabolism and effects of inhibitors. In: Obladen M, Koehne P, penyunting. Interventions for persisting ductus arteriosus in the preterm infant. 1st Ed. Berlin: Springer; 2005. p. 12-4.
Anilkumar M. Patent ductus arteriosus. Cardiol Clin. 2013;31(3):417-30.
Bernstein D. Patent ductus arteriosus. In: Kliegman RM, Stanton BF, St Geme JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 20th Ed. Philadelphia: Elsevier; 2016. p. 2197-8.
Sasi A, Deorari A. Patent ductus arteriosus in preterm infants. Indian Pediatrics. 2011;48(4):301-8.
Johnson W, Moller J. Anomalies with a left-to-right shunt in children. In: Johnson W, Moller J, editors. Pediatric cardiology: The essential pocket guide. 3rd Ed. Chennai: John Wiley & Sons; 2014. p. 118-27.
Sehgal A, Paul E, Menahem S. Functional echocardiography in staging for ductal disease severity : role in predicting outcomes. Eur J Pediatr. 2013;172(2):179-84.
Taggart NW, Qureshi MY. Patent ductus arteriosus and aortopulmonary window. In: Allen HD, Shaddy RE, Penny DJ, Feltes TF, Cetta F, editors. Moss and adams' heartdisease in infants, children, and adolescents including the fetus and young adult. 1. 9th Ed. Philadelphia: Wolters Kluwer; 2016. p. 803-14.
Sinha B. Controversies in management of patent ductus arterious in the preterm infant. J Pulmon Resp Med. 2013;01:13.
Baruteau AE, Hascoët S, Baruteau J, Boudjemline Y, Lambert V, Angel CY, et al. Transcatheter closure of patent ductus arteriosus: Past, present and future. Arch Cardiovasc Dis. 2014;107(2):122-32.
Rao PS, Sideris EB, Haddad J, Rey C, Hausdorf G, Wilson AD, et al. Transcatheter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial clinical experience. Circulation. 1993;88(3):1119-26.
Zulqarnain A, Younas M, Waqar T, Beg A, Asma T, Baig MA. Comparison of effectiveness and cost of patent ductus arteriosus device occlusion versus surgical ligation of patent ductus arteriosus. Pak J Med Sci. 2016;32(4):974-7.
Adhikari CM, Malla R, Shakya U, Shrestha M, Rauniyar B, Limbu D, et al. Transcatheter closure of patent ductus arteriosus at Shahid Gangalal National Heart Centre, Kathmandu, Nepal. J Adv Intern Med. 2017;6(1):1-3.
Yarrabolu T, Rao P. Transcatheter closure of patent ductus arteriosus. Pediatr Ther. 2012;01(S5):1-8.
Rathke J, Menezes HS, Rossi-Filho RI, Manica JLL. Percutaneous occlusion of patent ductus arteriosus. Rev Bras Cardiol Invasiva. 2014;22(4):364-8.
Amoogzar H, Shakiba AM, Derakhshan D, Ajami G, Cheriki S, Borzouee M, et al. Evaluation of left ventricular function by tissue doppler and speckle-derived strain rate echocardiography after percutaneous ductus closure. Pediatr Cardiol. 2015;36(1):219-25.
Gupta P, Gupta K, Jain M, Garg T. Postprocedural chest radiograph: Impact on the management in critical care unit. Ann Pediatr Card. 2011;4(2):139-44.
Ammar R, Hegazy R. Percutaneous closure of medium and large PDAs using amplatzer duct occluder (ADO) I and II in infants: Safety and efficacy. J Invasive Cardiol. 2012;24(11):579-82.
Park MK, Salamat M. Left-to-right shunt lesions. In: Park MK, editor. Park's the pediatric cardiology handbook. 5th Ed. Philadelphia: Elsevier; 2016. p. 108-11.
Cace N, Ahel V, Bilic I. Complete transcatheter closure of a patent arterial duct with subsequent haemolysis. Cardiol Young. 2010;20(4):462-4.
Azhar AS, Abd El-Azim AA, Habib HS. Transcatheter closure of patent ductus arteriosus: evaluating the effect of the learning curve on the outcome. Ann Pediatr Card. 2009;2(1):36-40.
Behjati-Ardakani M, Behjati-Ardakani MA, Hadadzadeh M, Moshtaghion SH, Sarebanhassanabadi M. Experience with percutaneous closure of ductus arteriosus using the amplatzer duct occluder in 243 consecutive patients and long-term results—a single centre study. Niger Med J. 2013;55(5):394-8.
Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the amplatzer occluder. Am Heart J. 2003;145(4):737-41.
Djer MM, Madiyono B, Sastroasmoro S. Blood nickel level and its toxic effect after transcatheter closure of persistent duct arteriosus using amplatzer duct occluder. Paediatr Indones. 2009;49(1):33-7.
Jang GY, Son CS, Lee JW, Lee JY, Kim SJ. Complications after transcatheter closure of patent ductus arteriosus. J Korean Med Sci. 2007;22(3):484-90.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
